Zal
Franck Zal, Morlaix-Ploujean FR
Patent application number | Description | Published |
---|---|---|
20100234275 | Use Of A High Molecular Weight Extracellular Hemoglobin For The Manufacture Of A Medicament For Treating And/Or Preventing Diseases By Inhibition Of Calcium - The present invent ion relates to the use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium. Advantageously, the extracellular hemoglobin is obtained from Annelids. In particular, the invention concerns the use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing cardiovascular diseases, such as hypertension, angina such as angina pectoris, Raynaud's disease, arteriopathy, tachycardia, vasospasm, ischemia, myocardial infarct ion, congestive heart failure, arrhythmia or cerebrovacular accident. | 09-16-2010 |
20100278887 | Use of a Haemoglobin for the Preparation of Dressings and Resulting Dressings - The invention relates to the use of a haemoglobin for the preparation of dressings and to the resulting dressings. | 11-04-2010 |
Franck Zal, Ploujean-Morlaix FR
Patent application number | Description | Published |
---|---|---|
20100209902 | Use of a Globin, a Globin Protomer or an Extracellular Hemoglobin for the Preservation of Organs, Tissues, Organ and Tissue Cells and Cell Cultures - The invention relates to the use of at least one globin and/or at least one globin protomer and/or at least one naturally extracellular native hemoglobin for the preservation of organs, tissues, organ and tissue cells and cell cultures. | 08-19-2010 |
20140113274 | ORGAN-PRESERVING COMPOSITION AND USES - The invention relates to the use of a composition comprising at least one globin, one globin protomer or one extracellular hemoglobin of Annelida, a stabilizing solution and/or a solution for conserving organs, said composition having a temperature of between 0° C. and 37° C., for preserving an organ in a donation after brain death donor or a donation after cardiac death donor. | 04-24-2014 |
20140220683 | USE OF ANNELID HAEMOGLOBIN FOR MAINTAINING STEM CELLS IN THE UNDIFFERENTIATED STATE - A method for maintaining stem cells in the undifferentiated state by mixing the stem cells with at least one extracellular hemoglobin, globin or globin protomer from annelids. | 08-07-2014 |
20150190343 | ANNELID HAEMOGLOBIN LYOPHILISATION PROCESS - The present invention relates to a lyophilizate comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants. The present invention also relates to a composition comprising: a solution comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants. | 07-09-2015 |
Franck Zal, Poujean-Morlais FR
Patent application number | Description | Published |
---|---|---|
20080305178 | USE OF A HIGH MOLECULAR WEIGHT EXTRACELLULAR HAEMOGLOBIN AS A BLOOD SUBSTITUTE - A blood substitute, of an extracellular haemoglobin having a molecular weight of approximately 3 to approximately 4 million daltons, comp sing chains of polymerised globins, containing free cysteines capable of binding to NO and/or SNO groups, and having a P | 12-11-2008 |
Franck Zal, Ploujeanmorlaix FR
Patent application number | Description | Published |
---|---|---|
20150374796 | USE OF HAEMOGLOBIN OF ANNELIDS FOR TREATING CANCER - A method for treating cancer using at least one globin, a globin protomer or an extracellular haemoglobin of annelids. | 12-31-2015 |
Frank Zal, Morlaix Cedex FR
Patent application number | Description | Published |
---|---|---|
20120040453 | BIOREACTOR USING OXYGEN-CARRYING MOLECULES - The present invention relates to devices and bioreactors capable of delivering oxygen to a cell culture using oxygen-carrying molecules. The bioreactor comprises at least two chambers separated by an oxygen-permeable membrane. The oxygen-carrying molecules are chosen from extracellular hemoglobin isolated from worm belonging to Arenicoliolae family or Nereidiolae family. | 02-16-2012 |